ProtoKinetix (PKTX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2026, filed Nov 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PKTX SEC filings page.
This page shows ProtoKinetix Inc (PKTX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The company remains a small, loss-making operation whose shrinking equity and financing inflows coexist with extremely thin liquidity.
From FY2023 to FY2025, total liabilities rose from$45K to$185K . Over the same span, total equity fell from$436K to$298K , so the balance sheet is carrying more obligations against a smaller capital base.
FY2025’s net loss was
The latest current ratio was 0.0x because current assets were only
Financial Health Signals
We do not publish a peer-relative financial health score for ProtoKinetix Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
ProtoKinetix Inc passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
ProtoKinetix Inc reported a net loss of $394K while operations used $135K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
ProtoKinetix Inc reported a net loss of $78K in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
ProtoKinetix Inc earned $0.00 per diluted share (EPS) in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q1 2026.
Not reported for Q1 2026.
Cash & Balance Sheet
ProtoKinetix Inc held $524 in cash as of Q1 2026; no long-term debt figure is on record for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
ProtoKinetix Inc's quarterly ROE was -31.4% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is down 5.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.8 percentage points.
Not reported for Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Capital Allocation
ProtoKinetix Inc invested $24K in research and development in Q1 2026. This represents a decrease of 28.4% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q1 2026.
Not reported for Q1 2026.
PKTX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | $24K-28.4% | $24K+15.3% | $24K+15.2% | $24K+16.2% | $34K-7.7% | $21K-42.4% | $21K-1.4% | $21K-34.3% |
| SG&A Expenses | $13K-14.2% | $13K-27.0% | $16K-0.1% | $14K+6.8% | $15K+4.4% | $18K+22.5% | $16K-1.7% | $13K-63.0% |
| Net Income | -$78Kn/m | -$120Kn/m | -$85Kn/m | -$91Kn/m | -$98Kn/m | -$103Kn/m | -$85Kn/m | -$85Kn/m |
| EPS (Basic) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| EPS (Diluted) | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| Diluted Shares (Avg) | 408M+9.0% | N/A | 389M+6.7% | 354M0.0% | 374M+12.3% | N/A | 365M+8.7% | 354M+5.5% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Operating Income, EBITDA, Interest Expense, Income Tax.
PKTX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $485K-8.3% | $483K+3.7% | $478K-0.3% | $474K+0.2% | $529K+14.6% | $466K-3.0% | $479K+6.3% | $474K+1.4% |
| Current Assets | $2K | $2K | N/A | N/A | N/A | N/A | $7K-49.9% | $3K-83.5% |
| Cash & Equivalents | $524-98.9% | $1K-76.2% | $607-89.3% | $112-94.9% | $49K+1644.6% | $5K-77.0% | $6K-54.1% | $2K-88.2% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $237K+56.0% | $185K+49.5% | $227K+158.9% | $149K+153.7% | $152K+125.3% | $124K+177.5% | $88K+598.5% | $59K+343.4% |
| Current Liabilities | $237K+56.0% | $185K+49.5% | $227K+158.9% | $149K+153.7% | $152K+125.3% | $124K+177.5% | $88K+598.5% | $59K+343.4% |
| Non-Current Liabilities | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Equity | $247K-34.3% | $298K-12.9% | $250K-36.0% | $325K-21.6% | $376K-4.4% | $342K-21.5% | $392K-10.7% | $415K-8.6% |
| Retained Earnings | -$48.7Mn/m | -$48.6Mn/m | -$48.5Mn/m | -$48.4Mn/m | -$48.3Mn/m | -$48.2Mn/m | -$48.1Mn/m | -$48.0Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
PKTX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$24Kn/m | $558n/m | -$4Kn/m | -$80Kn/m | -$52Kn/m | -$45Kn/m | -$39Kn/m | -$81Kn/m |
| Stock-Based Compensation | N/A | N/A | $0-100.0% | N/A | N/A | N/A | $1Kn/m | N/A |
| Investing Cash Flow | -$4Kn/m | -$20Kn/m | -$6Kn/m | -$5Kn/m | -$26Kn/m | -$5Kn/m | -$17Kn/m | -$26Kn/m |
| Financing Cash Flow | $27K-79.5% | $20K-50.0% | $10K-83.3% | $36K-66.5% | $132K+164.0% | $40K-63.6% | $60K-7.7% | $106K-39.4% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
PKTX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | -31.4%-5.5pp | -40.3%-10.3pp | -33.9%-12.3pp | -28.0%-7.5pp | -25.9%-2.6pp | -30.0%-4.2pp | -21.6%-3.3pp | -20.5%+5.0pp |
| Return on Assets | -16.0%+2.4pp | -24.8%-2.8pp | -17.8%-0.1pp | -19.2%-1.2pp | -18.5%+1.5pp | -22.0%+1.4pp | -17.6%+0.2pp | -18.0%+6.8pp |
| Current Ratio | 0.01 | 0.01 | N/A | N/A | N/A | N/A | 0.08-1.0x | 0.06-1.4x |
| Liabilities-to-Equity | 0.96+0.6x | 0.62+0.3x | 0.91+0.7x | 0.46+0.3x | 0.40+0.2x | 0.36+0.3x | 0.22+0.2x | 0.14+0.1x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| ProtoKinetix Inc PKTX | FY2025 | N/A | -$394K | N/A | $123K | — |
| Ocean Biomedical Inc OCEA | FY2024 | N/A | N/A | N/A | $93K | — |
| Sigyn Therapeutics Inc SIGY | FY2024 | N/A | N/A | N/A | $150K | — |
| CERo Terapeutics Holding Inc CERO | FY2025 | N/A | N/A | N/A | $149K | — |
| Vincerx Pharma Inc VINC | FY2024 | N/A | -$30.1M | N/A | $79K | — |
| Regen BioPharma Inc RGBP | FY2025 | $237K | -$1.3M | N/A | $406K | — |
Where ProtoKinetix Inc Ranks
Frequently Asked Questions
No, ProtoKinetix Inc (PKTX) reported a net loss of $374K over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net loss of $394K.
ProtoKinetix Inc (PKTX) has a return on equity of -132.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
ProtoKinetix Inc (PKTX) recorded an outflow of $135K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
ProtoKinetix Inc (PKTX) had $483K in total assets as of fiscal year 2025, including both current and long-term assets.
ProtoKinetix Inc (PKTX) invested $107K in research and development during fiscal year 2025.
ProtoKinetix Inc (PKTX) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
ProtoKinetix Inc (PKTX) had a liabilities-to-equity ratio of 0.62 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
ProtoKinetix Inc (PKTX) had a return on assets of -81.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
ProtoKinetix Inc (PKTX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to March 31, 2026). The market capitalization is $123K as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
ProtoKinetix Inc (PKTX) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $123K as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
At the end of fiscal year 2025, ProtoKinetix Inc (PKTX) held $1K in cash, cash equivalents and investments, and reported an operating cash outflow of $135K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
ProtoKinetix Inc (PKTX) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
ProtoKinetix Inc (PKTX) reported a net loss of $394K while operations used $135K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.